Crescent Biopharma, Inc. employees and revenue per employee

CBIO · Biotechnology · $554M market cap

Crescent Biopharma, Inc. had 44 employees at the end of fiscal Dec 2025. Revenue for the year was $10.8M, or $246K per employee.

Employees

44

Revenue

$10.8M

Revenue / employee

$246K

Peer median $459K

Rank in industry

78 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2016
03165163301'16'20'21'22'23'25Revenue 58616Staff 105

Hover a year for the numbers.

CBIO employees and revenue by fiscal year
Year endingEmployeesRevenuePer employeeStaff YoYRevenue YoY
Dec 202544$10.8M$246K——
Dec 202335$10,000$286-7.9%-86.7%
Dec 202238$75,000$2K-26.9%-93.5%
Dec 202152$1.2M$22K-3.7%-88.6%
Dec 202054$10.2M$188K——
Dec 201642$18,500$440——

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years
42'1654'2052'2138'2235'2344'25
Revenue per employee, last six fiscal years
$440'16$188K'20$22K'21$2K'22$286'23$246K'25

Crescent Biopharma, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
CBIO
Crescent Biopharma, Inc.
44$10.8M$246K—
JANX
Janux Therapeutics, Inc.
109$10.0M$92KHiring into decline
RLAY
Relay Therapeutics, Inc.
192$15.4M$80KLeaner
PRAX
Praxis Precision Medicines, Inc.
116$8.6M$74KEfficient growth
PGEN
Precigen, Inc.
160$9.7M$61KEfficient growth
ZBIO
Zenas BioPharma, Inc.
167$10.0M$60KEfficient growth
IMNM
Immunome, Inc.
177$6.9M$39KHiring into decline
CRNX
Crinetics Pharmaceuticals, Inc.
594$7.7M$13KEfficient growth
AKTS
Aktis Oncology, Inc.
200,000$6.5M$32—
Every Healthcare company

Questions about Crescent Biopharma, Inc.

How many employees does Crescent Biopharma, Inc. have?
Crescent Biopharma, Inc. reported 44 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026.
What is Crescent Biopharma, Inc.'s revenue per employee?
Crescent Biopharma, Inc. brought in $10.8M of revenue in fiscal Dec 2025, which is $246K per employee. That ranks 78 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare CBIO with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Crescent Biopharma, Inc.'s annual reports (Form 10-K), latest filed February 26, 2026. This is data, not a recommendation to buy or sell CBIO.